UNSPSC 51285201: Baquiloprim

This classification denotes an antiprotozoal agent with the molecular formula C17H20N6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3DE766VIG6, chemically known as 5-((2,4-diamino-5-pyrimidinyl)methyl)-8-(dimethylamino)-7-methylquinoline but more generally known as baquiloprim, which bears US NIH Compound Identifier 72121. European Medicines Agency schedules Baquiloprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06100MIG. The term BAQUILOPRIM is an International Non-Proprietary Name.

BAQUILOPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51285201 Baquiloprim is a Commodity code for a specific pharmaceutical product, but state and local procurement activity under this code tag shows minimal recent alignment with the nominal product. The two most recent recorded opportunities tagged to this code involve unrelated pharmaceuticals: one Illinois Department of Public Health piggyback contract award for Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through the MMCAP Infuse cooperative purchasing vehicle, and one Seminole County, Florida competitive bid for Naloxone and Safe Drug Deactivation Systems. Neither solicitation concerns Baquiloprim itself. The code's recent activity reflects state health departments and county health offices procuring emergency medical and infectious-disease pharmaceuticals through cooperative purchasing agreements and traditional sealed bids, but the mismatch between the code's stated commodity and the actual products being purchased suggests either miscoding in the source data or that this UNSPSC designation sees little if any procurement activity aligned with its definition.

Geographic activity appears limited to Florida and Illinois based on the two recorded opportunities. The Illinois Department of Public Health's $2,999,999.11 three-year piggyback award to Chartwell Rx LLC closed on August 28, 2026, and Seminole County's IFB for Naloxone and deactivation systems carried a response deadline of July 26, 2023 — a date now substantially past. No open solicitations under this code are currently active. Business development professionals evaluating this code should verify whether the UNSPSC designation accurately reflects their product line; if Baquiloprim is the actual target, the miscoding in recent opportunities suggests this code generates minimal relevant state and local procurement volume at present.